EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access · CC BY 4.0

Hepatic Phenotype in NBAS‐Associated Disease: Clinical Course, Prognostic Factors and Outcome in 230 Patients

Bianca Peters iD, Lea Dewi Schlieben, Heiko Brennenstuhl, Cigdem Arikan iD, Sarah M Bedoyan, Fatma Derya Bulut, Ellen Crushell, Carlo Dionisi-Vici, Ada Drab iD, Alexander Fichtner, Aixa Gonzalez Garcia iD, Deanna Fry und 21 weitere

Liver International · 2025

DOI: 10.1111/liv.70146 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Liver International, 2025. Verfasst von Bianca Peters und 32 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Neurology and Metabolic Medicine, Department of Pediatrics I, Medical Faculty of Heidelberg, Heidelberg University, Heidelberg,…. Hauptthemen laut MEDLINE: Liver Failure, Acute. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, Dietmar Hopp Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Since described in 2015, NBAS‐associated disease has emerged as an important cause of acute liver failure (ALF) in children. We analysed the variable expression, genotype–phenotype association, outcome and prognostic factors of the hepatic involvement.

Methods

Individuals with biallelic pathogenic NBAS variants were recruited within an international observational study, including new and previously published patients.

Results

We studied 230 individuals, including 13 previously unreported patients. The liver was the most frequently affected organ (63.4%), with 41.3% experiencing at least one ALF. The median age at onset was 0.9 years, the median age at last ALF 5 years, the latest ALF occurred at 24 years. Liver crises were triggered by febrile infections and presented with highly increased hepatic transaminases. Liver involvement varied significantly between the subgroups: 91.7% of patients with infantile liver failure syndrome type 2 and 88.9% of patients from the combined subgroup (variants affecting β‐propeller domain) presented with ALF, whereas SOPH (stature, optic atrophy, Pelger–Huët anomaly) patients mostly had either no liver involvement (66.4%) or persistently elevated transaminases without ALF (28%). The rate of native liver survival was 83.9%; 16 individuals underwent liver transplantation and 24 died.

Conclusion

Liver abnormalities are common and the leading cause of death in NBAS‐associated disease. There is a clear genotype–phenotype association regarding the hepatic involvement. Liver crises occur primarily during infancy; however, early medical attention in case of febrile infections is necessary at all ages. Liver transplantation prevents ALF, but its risks must be weighed against the frequency and severity of liver crises decreasing with age.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver Failure, AcuteHumansMaleFemaleChild, PreschoolInfantChildPhenotypePrognosisAdolescentYoung AdultAdultLiverLiver TransplantationGenetic Association StudiesAge of OnsetNeoplasm Proteins

Stichwörter der Autor:innen

NBASdisorders of intracellular traffickinggenetic liver diseaseinfantile liver failure syndrome type 2recurrent acute liver failure

Substanzen

NBAS protein, humanNeoplasm Proteins

Autor:innen und Institutionen

  • Division of Pediatric Neurology and Metabolic Medicine, Department of Pediatrics I, Medical Faculty of Heidelberg, Heidelberg University, Heidelberg, Germany.
  • European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany.
  • European Reference Network on Hereditary Metabolic Disorders (MetabERN), Udine, Italy.
  • School of Medicine, Institute of Human Genetics, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
  • Institute of Neurogenomics, Computational Health Centre, Helmholtz Munich, Munich, Germany.
  • Institute of Human Genetics, Heidelberg University and University Hospital Heidelberg, Heidelberg, Germany.

ORCID-Profile: Bianca Peters, Cigdem Arikan, Ada Drab, Aixa Gonzalez Garcia, Nicole Hammann, Marianne Hørby Jørgensen, Andrea Pietrobattista, James E Squires, Georg F Vogel, Stefan Kölker, Georg F Hoffmann, Christian Staufner, Dominic Lenz

Förderung

  • NICHD NIH HHS
  • Dietmar Hopp Stiftung

Zitieren

APA

Peters, B., Schlieben, L. D., Brennenstuhl, H., Arikan, C., Bedoyan, S. M., Bulut, F. D., Crushell, E., Dionisi-Vici, C., Drab, A., Fichtner, A., Garcia, A. G., Fry, D., Garbade, S. F., Hammann, N., Hadzic, N., Hegarty, R., Jørgensen, M. H., Laaß, M., Lainka, E., …, & Lenz, D. (2025). Hepatic Phenotype in NBAS‐Associated Disease: Clinical Course, Prognostic Factors and Outcome in 230 Patients. Liver International. https://doi.org/10.1111/liv.70146

Vancouver

Peters B, Schlieben LD, Brennenstuhl H, Arikan C, Bedoyan SM, Bulut FD, et al. Hepatic Phenotype in NBAS‐Associated Disease: Clinical Course, Prognostic Factors and Outcome in 230 Patients. Liver International. 2025. doi:10.1111/liv.70146

BibTeX
@article{Peters2025,
  author = {Peters, Bianca and Schlieben, Lea Dewi and Brennenstuhl, Heiko and Arikan, Cigdem and Bedoyan, Sarah M and Bulut, Fatma Derya and Crushell, Ellen and Dionisi-Vici, Carlo and Drab, Ada and Fichtner, Alexander and Garcia, Aixa Gonzalez and Fry, Deanna and Garbade, Sven F and Hammann, Nicole and Hadzic, Nedim and Hegarty, Robert and Jørgensen, Marianne Hørby and Laaß, Martin and Lainka, Elke and Leghlam, Lina and Lurz, Eberhard and Mungan, Halise Neslihan Önenli and Pietrobattista, Andrea and Polo, Begona and Socha, Piotr and Squires, James E and Sun, Tian and Vogel, Georg F and Prokisch, Holger and Kölker, Stefan and Hoffmann, Georg F and Staufner, Christian and Lenz, Dominic},
  title = {Hepatic Phenotype in NBAS‐Associated Disease: Clinical Course, Prognostic Factors and Outcome in 230 Patients},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.70146}
}
Kostenlos starten →